Company Data

Kineta Inc.

Ticker
KA
Price Target
Refer to Report
Volume
1.5M
52wk Range
$0.3339 - $5.39
Advanced Market Data

Overview

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company’s lead asset is KVA12.1, a VISTA blocking immunotherapy.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy